Skip to content

Advertisement

BMC Cancer

What do you think about BMC? Take part in

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

FOXP3 Is a HCC suppressor gene and Acts through regulating the TGF-β/Smad2/3 signaling pathway

  • Jie-Yi Shi1,
  • Li-Jie Ma1,
  • Ji-Wei Zhang2,
  • Meng Duan1,
  • Zhen-Bin Ding1,
  • Liu-Xiao Yang1,
  • Ya Cao3,
  • Jian Zhou1, 4,
  • Jia Fan1, 4,
  • Xiaoming Zhang5,
  • Ying-Jun Zhao2,
  • Xiao-Ying Wang1Email author and
  • Qiang Gao1Email author
Contributed equally
BMC Cancer201717:648

https://doi.org/10.1186/s12885-017-3633-6

Received: 19 March 2017

Accepted: 28 August 2017

Published: 13 September 2017

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
19 Mar 2017 Submitted Original manuscript
12 Apr 2017 Reviewed Reviewer Report - Zhengyu Zha
19 Apr 2017 Reviewed Reviewer Report - Marcus Hollenbach
7 May 2017 Author responded Author comments - Jie-Yi Shi
Resubmission - Version 2
7 May 2017 Submitted Manuscript version 2
11 Aug 2017 Author responded Author comments - Jie-Yi Shi
Resubmission - Version 3
11 Aug 2017 Submitted Manuscript version 3
20 Aug 2017 Author responded Author comments - Jie-Yi Shi
Resubmission - Version 4
20 Aug 2017 Submitted Manuscript version 4
22 Aug 2017 Author responded Author comments - Jie-Yi Shi
Resubmission - Version 5
22 Aug 2017 Submitted Manuscript version 5
Publishing
28 Aug 2017 Editorially accepted
13 Sep 2017 Article published 10.1186/s12885-017-3633-6

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Liver Cancer Institute, Zhongshan Hospital, and Key Laboratory of Carcinogenesis and Cancer Invasion (Ministry of Education), Fudan University
(2)
Cancer Research Institute, Fudan University Shanghai Cancer Center
(3)
Cancer Research Institute, Xiangya School of Medicine, Central South University
(4)
Institute of Biomedical Sciences, Fudan University
(5)
Key Laboratory of Molecular Virology & Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences

Advertisement